Peripheral opiate action on afferent fibres supplying the rat intestine

Neurogastroenterology and Motility

Volumn 16, Issue SUPPL. 2, 2004, Pages 29-37

  Grundy, D ^a   Booth, C E ^b   Winchester, W ^b   Hicks, G A ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 HT; Afferents; Bradykinin; Mechanosensitivity; Opiate analgesic; Opioids; Small intestine

Indexed keywords

2 METHYLSEROTONIN; ALVIMOPAN; BRADYKININ; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL TRACT FUNCTION; INTESTINE DISTENSION; INTESTINE INNERVATION; MALE; MECHANICAL STIMULATION; NERVE POTENTIAL; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CONDUCTION; SPINAL NERVE; VAGUS NERVE;

ACTION POTENTIALS; ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; JEJUNUM; MALE; NARCOTICS; NEURONS, AFFERENT; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

EID: 7944227788     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1743-3150.2004.00557.x     Document Type: Article

References (32)

1. Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003; 63: 649-71.
2. Su X, Sengupta JN. Opioids in visceral pain. In: Stein C, ed. Opioids in Pain Control: Basic and Clinical Aspects. Cambridge: Cambridge University Press, 1999: 325-34.
3. Stein C, Schafer M, Machelska H. Attacking pain at its source, new perspectives on opioids. Nat Med 2003; 9: 1003-7.
4. Sternini C. Receptors and transmission in the brain-gut axis: potential for novel therapies III. μ-opioid receptors in the enteric nervous system. Am J Physiol 2001; 281: G8-15.
5. Taguchi A, Sharma N, Saleem RM et al. Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl J Med 2001; 345: 935-40.
6. Liu SS, Hodgson PS, Carpenter RL, Fricke JR Jr. ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia. Clin Pharmacol Ther 2001; 69: 66-71.
7. Poonyachoti S, Kulkarni-Narla A, Brown DR. Chemical coding of neurones expressing δ- and κ-opioid receptor and type 1 vanilloid receptor immunoreactivities in the porcine ileum. Cell Tissue Res 2001; 307: 23-33.
8. Su X, Sengupta JN, Gebhart GF. Effects of kappa opioid receptor-selective agonists on responses of pelvic nerve afferents to noxious colorectal distension. J Neurophysiol 1997; 78: 1003-12.
9. Sengupta JN, Snider A, Su X, Gebhart GF. Effects of kappa opioids in the inflamed rat colon. Pain 1999; 79: 175-85.
10. Su X, Julia V, Gebhart GF. Effects of intracolonic opioid receptor agonists on polymodal pelvic nerve afferent fibers in the rat. J Neurophysiol 2000; 83: 963-70.
11. Su X, Wachtel RE, Gebhart GF. Inhibition of calcium currents in rat colon sensory neurons by K- but not μ- or δ-opioids. J Neurophysiol 1998; 80: 3112-9.
12. Su X, Joshi SK, Kardos S, Gebhart GF. Sodium channel blocking actions of the κ-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects. J Neurophysiol 2002; 87: 1271-9.
13. Ozaki N, Sengupta JN, Gebhart GF. Differential effects of mu-, delta-, and kappa-opioid receptor agonists on mechanosensitivegastric vagal afferent fibres in the rat. J Neurophysiol 2000; 83: 2209-16.
14. Randich A, Thurston CL, Ludwig PS, Robertson JD, Rasmussen C. Intravenous morphine-induced activation of vagal afferents, peripheral, spinal, and CNS substrates mediating inhibition of spinal nociception and cardiovascular responses. J Neurophysiol 1992; 684: 1027-45.
15. Diop L, Riviere PJ, Pascaud X, Dassaud M, Junien JL. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats. Eur J Pharmacol 1994; 257: 181-7.
16. Randich A, Gebhart GF. Vagal afferent modulation of nociception. Brain Res Rev 1992; 17: 77-99.
17. Eastwood C, Grundy D. Opioid receptor mediated excitation of rat mesenteric afferent fibres supplying the rat jejunum. Neurogastroenterol Motil 2000; 12: 517-22.
18. Schmidt WK. Alvimopan (ADL 8-26989) is a novel peripheral opioid antagonist. Am J Surg 2001; 182 (Suppl.): 27S-38S.
19. Booth CE, Kirkup AJ, Hicks GA, Humphrey PP, Grundy D. Somatostatin sst(2) receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology 2001; 121: 358-69.
20. Randich A, Robertson JD, Willingham T. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine. Brain Res 1993; 603: 186-200.
21. Dhawan BN, Raghubir R, Hamon M. Opioid receptors. In: The IUPHAR Database on Receptor Nomenclature and Drug Classification, 2002. Available at: http://www.iuphar-db.org.
22. Kirkup AJ, Booth CE, Chessell IP, Humphrey PPA, Grundy D. Excitatory effect of P2X receptor activation on mesenteric afferent nerves in the anaesthetised rat. J Physiol 1999; 520: 551-63.
23. Hillsley K, Grundy D. Sensitivity to 5-hydroxytryptamine in different afferent subpopulations within mesenteric nerves supplying the rat jejunum. J Physiol 1998; 509: 717-27.
24. Richards W, Hillsley K, Eastwood C, Grundy D. Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat. J Physiol 1996; 497: 473-81.
25. Grain SM, Shen KF. Opioids can evoke direct receptor mediated excitatory effects on sensory neurons. Trends Pharmacol Sci 1990; 11: 77-81.
26. Smart D, Lambert DG. The stimulatory effects of opioids and their possible role in the development of tolerance. Trends Pharmacol Sci 1996; 17: 264-9.
27. Crain SM, Shen KF. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol Sci 1998; 19: 358-65.
28. Shen KF, Crain SM. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res 1997; 757: 176-90.
29. Kirkup AJ, Brunsden AM, Grundy D. Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am J Physiol 2001; 280: G787-94.
30. Grundy D, Reid K. The physiology of nausea and vomiting. In: Johnson LR, ed. Physiology of the GI Tract, 3rd edn. New York: Raven Press, 1994: 879-902.
31. Aicher SA, Goldberg A, Sharma S, Pickel VM. mu-opioid receptors are present in vagal afferents and their dendritic targets in the medical nucleus tractus solitarius. J Comp Neurol 2000; 422: 181-90.
32. Feinle C, Grundy D, Otto B, Fried M. Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans. Am J Physiol 2000; 278: R1217-23.